TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
OMER

Omeros Corporation

Healthcare · Biotechnology

20.70$ -1.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 326 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
27 22 62 46 27 27 17 11 49 67 116 96 137 181 419 591 378 277 326
24 20 61 44 26 25 15 9.2 37 60 108 90 104 151 248 443 218 134 216
5.9 13 0.8 3.3 4.0 1.5 1.4 0.4 1.4 2.2 3.4 5.9 3.1 11 101 11 7.1 3.4 9.7
24 20 60 42 25 22 14 6.9 28 45 84 60 61 135 157 195 172 90 172
0.2 0.2 0.2 1.5 0.9 1.9 0.4 0.4 6.5 12 17 23 35 3.8 82 242 6.7 37 36
0.0 0.0 0.0 0.6 0.5 1.1 0.4 53 48 115 0.0 8.6
0.8 0.9 1.1 1.6 0.7 1.0 0.9 0.8 1.0 1.2 2.1 3.8 3.8 28 30 23
0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
97 113 19 25 33 241 35 54 75 105 119 -4.2 246 302 395 505 403 460 447
7.9 24 11 16 19 9.3 12 18 16 16 26 37 55 37 52 136 53 80 78
1.0 17 4.9 0.4 5.9 5.6 6.4 0.1 0.2 0.5 0.9 3.5 3.8 5.3 99 14 27 23
2.6 1.2 2.6 2.4 2.0 2.6 2.3 4.9 6.4 2.5 6.7 6.3 5.3 4.2 13 6.0 7.7 5.9 4.8
0.1 7.8 9.4 14 20 15 26 50 80 84 149 158 236 313 221 213 167 209
-70 -91 43 20 -5.6 -215 -18 -43 -26 -37 -2.8 650 -109 -121 24 86 -25 -183 -121
-73 -97 -118 -148 -176 -215 -254 -328 -403 -470 -523 650 -735 -873 -683 -636 -754 -910 -914
14 14 14 11 7.2 21 22 24 29 33 38 40 46 49 50 57 62 63 63 58 64

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?